Hospitalist · Rochester, NY
NPI
1760745145
Since 2012
Specialty
Hospitalist
Code 208M00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1425 Portland Ave
Rochester, NY, 14621
Phone (585) 922-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
331 services
Medicare patients, 2024
177
Average age 68
Drug cost, 2024
$3.6M
6,835 prescriptions
Company payments, 2025
$33K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salman M Azim was code 99214 (office e&m - established), 267 times for 137 patients. In total Salman M Azim billed 331 services in 12 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 267 | 137 | $62.38 | $17K |
| 99204 Office E&M - New | Office | 22 | 22 | $78.41 | $1,725 |
By year: 2022 $22K for 323 services; 2023 $24K for 369 services; 2024 $21K for 331 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 17 | 13 | $8.96 | $152 |
Medicare prescription drug claims, 2024
In 2024, the drug Salman M Azim prescribed most often to Medicare patients was Ozempic (Semaglutide), with 759 prescriptions and refills. In total Salman M Azim wrote 6,835 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 759 | 952 | 138 | $889K |
| Jardiance Empagliflozin | 586 | 1,073 | 137 | $601K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 543 | 1,101 | 166 | $79K |
| Levothyroxine Sodium Generic | 456 | 1,063 | 135 | $5,415 |
| Trulicity Dulaglutide | 362 | 665 | 108 | $641K |
| Metformin Hcl Generic | 299 | 678 | 90 | $2,883 |
| Metformin Hcl Er Metformin Hcl | 231 | 519 | 75 | $2,975 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 195 | 330 | 70 | $57K |
| Glipizide Generic | 189 | 444 | 60 | $1,699 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 185 | 405 | 68 | $15K |
| Mounjaro Tirzepatide | 173 | 202 | 43 | $214K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 166 | 316 | 47 | $87K |
| Glipizide Er Glipizide | 127 | 298 | 42 | $1,769 |
| Atorvastatin Calcium Generic | 115 | 271 | 37 | $885 |
| Novolog Flexpen Insulin Aspart | 112 | 190 | 40 | $27K |
Brand drugs: 4,068 claims; generic drugs: 2,019 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salman M Azim $33K ($33K in general payments such as food, travel and fees) from 2 companies. The largest payer was Lilly USA, LLC with $33K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.